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ABSTRACT 
Background 
Nurse Independent and Nurse Supplementary Prescribing has extended the role that 
nurses in the UK have in the management of care for patients with diabetes. Concerns 
surround nurses’ pharmacological knowledge and provision of continuing 
professional development (CPD) to meet the needs of nurse prescribers. 
Aim 
To examine the CPD needs of nurses who prescribe medicines to patients with 
diabetes 
Methods 
The NMC database was used to randomly select and distribute questionnaires to 1992 
registered Nurse Independent/ Nurse Supplementary Prescribers. 1400 questionnaires 
were returned. Medicines for patients with diabetes were prescribed by 439 
respondents. This paper reports on the findings of these 439 nurses.  
Results 
The majority (63%) of nurses worked in general practice. Over 80% reported CPD 
was available and that they had accessed it to support their prescribing role. Over 40% 
of nurses had CPD needs in the areas of prescribing policy, pharmacology for 
diabetes, and the management and treatment of diabetes related conditions. Senior 
nurses reported fewer CPD needs.  
Conclusion 
Access and provision of CPD for nurse prescribers has improved since the initial 
implementation of nurse prescribing. However, nurse’s pharmacological knowledge 
and the provision of CPD continue to be an area of concern which warrant further 
investigation. 
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RELEVANCE TO CLINICAL PRACTICE 
 Previous concerns have been identified about the provision of CPD to meet the needs 
of nurse prescribers. Pharmacological knowledge is still the greatest CPD requirement 
of nurses who prescribe for patients with diabetes. Education providers may wish to 
consider developing the content of CPD programmes to meet these needs. 
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INTRODUCTION 
Recent developments within the United Kingdom (UK) National Health Service, 
technological advances and changing health care needs require ever more innovative, 
flexible, knowledgeable and highly skilled  nurses (DoH 1998, Wood 1998). In order 
to deliver these modern patient-centred services (DoH 2000, DoH 2007) there has 
been continued emphasis on the role expansion of nurses (DoH 1999b). 
 
There is evidence that nurses have key roles in the delivery of care in a number of 
areas, including chronic diseases (Campbell 2004, McKee & Nolte 2004, Raftery et 
al. 2005, Courtenay & Carey 2006). It is  also evident, that nurses working in a 
variety of roles, are involved in the treatment management of patients with diabetes 
(Carey & Courtenay 2007, Courtenay & Carey 2008b) and its common complications 
(such as hypertension, hyperlipidemia and cardiovascular disease (CVD)) (New et al. 
2003, Denver et al. 2003, Courtenay & Carey 2008b). 
  
Much of the care for people with diabetes mellitus is undertaken in primary care 
(Goyder et al. 1998, DoH 2005, DoH 2007),  and the role of the nurse in the care of 
these patients is emphasized by the by the National Service Framework (NSF) for 
Diabetes (DoH 2003a). The prescription of medicines by nurses (most of whom are in 
primary care) (Courtenay & Carey 2008a) therefore provides an opportunity to 
optimise the role of the nurse in service delivery for these patients.  
 
During the last decade the policy surrounding the prescription of medicines by nurses 
in the UK has undergone several changes. Any appropriately qualified community 
nurse is able to assess, diagnose and prescribe independently from a limited list of 
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medicines included in the Nurse Prescribers’ Formulary (NPF) for Community 
Practitioners. Similarly, following assessment and diagnosis of the patient, Nurse 
Independent Prescribers (NIP) are able to prescribe any licensed medicine (and some 
controlled drugs (CDs)) independently provided that it is within their area of 
competence (DoH 2006). Whilst Nurse Supplementary Prescribers (NSP) are also 
able to prescribe any medicine (including unlicensed medicines and CDs) (DoH 
2003b), in contrast to NIP this only takes place after assessment and diagnosis of the 
patients condition has been made by a doctor, and a Clinical Management Plan (CMP) 
(which includes a list of medicines from which the NSP feels competent to prescribe) 
has been agreed between the nurse, doctor and patient. Supplementary prescribing is 
particularly suited to the care of patients with chronic conditions such as diabetes, or 
heart disease. Such patients frequently have multiple co-morbidities and nurses may 
only feel confident to prescribe for these conditions when using a CMP.  
  
The need for nurses to acquire specialist knowledge prior to undertake the prescribing 
programme is a necessary prerequisite (Nursing and Midwifery Council (NMC) 
2006).  Training for Nurse Independent and Nurse Supplementary Prescribing is 
combined i.e. nurses successfully completing the prescribing programme are awarded 
the dual qualification of Nurse Independent/ Supplementary Prescriber.   
 
 
In order that nurses are able to provide high quality and evidence based care they need 
to participate in continuing professional development (CPD) (DoH 1999a, Audit 
Commission 2001, Nolan et al. 2000). In the UK the NMC code of professional 
conduct also stipulates that registered nurses must maintain their professional 
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knowledge and competence throughout their working life (NMC 2006). This is 
particularly important for nurses who are involved in new and developing areas of 
practice such as nurse prescribing. 
Current figures from Diabetes UK indicate that there are approximately 1,500 
diabetes specialist nurses (DSNs) across the UK (Diabetes UK 2008). Of the 13,000 
nurses across the UK  now able to prescribe both as NIPs and NSPs (NMC 2007) it is 
evident that approximately 400 of these DSNs are qualified NIP/NSPs (Courtenay et 
al. 2007b). It is also evident that there are over 2,500 qualified NIPs and NSPs 
working in general practice and prescribing for people with diabetes (Courtenay et al. 
2007b). Given the recent legislative changes surrounding the prescription of 
medicines by these nurses it is important to understand their CPD needs and also to 
identify key issues that are likely to arise. Although there is some evidence available 
examining the CPD needs of NIPs and NSPs, there is no evidence available 
specifically examining the needs of nurses who prescribe for people with diabetes. 
 
BACKGROUND 
Although evidence suggests that nurses are generally positive about the adoption of 
the role of prescriber (Latter et al 2005), some concerns have been identified 
surrounding the level of nurses’ pharmacological knowledge and the provision of 
CPD. For example Otway (2002), conducted a  survey of over 200 Health Visitor 
(HV)/District Nurse (DN) Prescribers in one NHS Trust to explore the development 
needs of nurse prescribers. It was evident from the findings that pharmacological 
knowledge was the most significant training need. In support of these findings, Sodha 
et al. (2002) in a survey of 110 community nurses, used case study vignettes to assess 
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nurse confidence and their ability to integrate applied pharmacology in to practice. 
Findings identified that most nurse prescribers had inadequate pharmacological 
knowledge to undertake their role as a prescriber. 
 
In an earlier study that was conducted  to identify the infrastructure  necessary to 
support nurse prescribing Humphries and Green (2000) undertook 12 focus group 
discussions using a convenience sample of 146 students (DN and HV) on a nurse 
prescribing programme. Keeping up to date with new products and their 
pharmacological properties, and CPD were areas that were identified as necessary to 
support prescribing by nurses. Also examining HV/DN prescribers, Luker and 
McHugh (2002) conducted a survey of 164 DN/HV prescribers in three Primary Care 
Trusts (PCTs) to identify the support structures in place for prescribers. Key concerns 
identified by these researchers were the lack of regular updates and clinical 
supervision to support nurses in this role. 
 
National evaluations of nurse prescribing in the UK have been undertaken by Latter et 
al. (2005) and Courtenay et al. (2007a) respectively.  The most frequently reported 
areas of CPD need reported by the 246 independent extended prescribers surveyed by 
Latter et al. (2005)  in 2003 were regular updates, training for expansion of the 
formulary, CPD related to area of practice, and access to local prescribing group 
meetings. 
 
Similarly, the most frequently reported areas of CPD needs reported by the 868 
independent extended supplementary prescribers surveyed by Courtenay et al. 
(2007a) in 2005 were an update of prescribing policy, treatment management of 
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conditions and pharmacology. Additionally, nurses in this study who worked in 
primary care reported a greater number of CPD needs. Participants in both Latter et 
al. (2005) and Courtenay et al. (2007a) studies reported that CPD was an important 
factor that facilitated prescribing.  
 
Whilst CPD and keeping up to date is not specific to nurse prescribing, it is evident  
that in general qualified nurses experience a number of difficulties with respect to the 
provision of, and access to CPD. These difficulties include time, money, work load 
pressures, lack of support, work pattern, and type of job (Barriball & While 1996, 
Wood 1998, Nolan et al. 2000). 
 
For example, Barriball & While (1996) used semi structured interviews to examine 
the level of participation in CPD among a group of 269 qualified nurses. Although 
80% of nurses had attended at least 5 study days, these researchers identified that 
many different levels and groups of nurses were disadvantaged with respect to 
accessing CPD.  A significantly greater number of participants who were in high 
position jobs i.e. grade F-H or higher had attended 5 continuing professional 
education (CPE) days in the last 3 years or more, compared to nurses who were in 
lower grade positions i.e. grade C-E . It was evident from the findings that nurses 
working in the hospital setting tended to attend less CPE days than nurses who were 
based in the community. Other disadvantaged groups were found to be those aged 
over 35 years of age, enrolled nurses, and those working night duty or part-time.   
 
More recently, Nolan et al. (2000) used focus groups and interviews with 236 nurses, 
nurse educators, service managers and mentors, and a survey of 1,500 nurses across 
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Wales to investigate the potential outcomes of CPD from the perspectives of 
practitioners and managers.  Whilst a number of  positive outcomes from CPD were 
identified (including organisational benefits, improved patient care, knowledge and 
confidence),  similar to Barriball & While (1996), these researchers identified that 
nurses who worked part-time, on night duty or in the independent sector were also 
disadvantaged with respect to accessing CPD. 
 
It is evident from the literature that there are concerns surrounding nurses’ level of 
pharmacological knowledge and the provision of CPD to meet the needs of nurse 
prescribers. This evidence has mainly been derived from the prescription of medicines 
by HVs and DNs and early independent prescribers. Although not specifically 
focussing on nurse prescribing, there is significant evidence that provision in general 
is inequitable.  There is no research available that has explored the CPD needs of 
nurses who prescribe medicines for patients with diabetes. This is important given 
that evidence to date (Courtenay & Carey 2008b) has shown that diabetes is a 
condition for which NIPs and NSPs frequently prescribe. 
 
AIM 
The aim of the study was to provide a national evaluation of Nurse Independent and 
Nurse Supplementary Prescribing in diabetes in the UK. A key component was to 
examine the continuing professional development (CPD) needs of these nurses. This 
component forms the focus of this paper. 
METHODS 
A survey design was used, with a postal questionnaire. The data were collected 
between October and December 2006. 
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Participants 
The participants were 439 nurses located throughout the UK. All nurses were 
qualified NIPs/NSPs and registered on the NMC data base. All prescribed medicines 
for patients with diabetes.   
 
Reliability and Validity  
A questionnaire booklet was developed for the purpose of the study. Its content was 
developed from previous work involving independent extended and supplementary 
nurse prescribers (Latter et al. 2005, Courtenay et al. 2007a), and a search of the 
literature of nurse-led care in diabetes (Carey & Courtenay 2007). The questionnaire 
was piloted on 20 qualified NIPs/NSPs who prescribed for patients with diabetes. 
They were asked to comment on its ease of completion, and any difficulties 
understanding what was required of them at any point throughout the questionnaire. It 
was evident that the format and content of the questions were appropriate, and only 
minor refinements and amendments were made. Following data entry of the 
completed questionnaires 10% were then reviewed by one of the authors (NC). There 
was agreement between the data that had been entered and NC. 
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Questionnaire 
The first page contained some simple instructions on how to complete the questions. 
The first section of the questionnaire, collected general demographic information, 
details about participants specialist training in diabetes and level of experience in their 
area of practice.  
The next section asked respondents about CPD. Participants were asked to specify 
their CPD needs with respect to diabetes prescribing practice within the next, or after 
the next 12 months including: update on prescribing policy, diabetes knowledge, 
assessment and diagnosis of diabetes, management and treatment of diabetes, 
management and treatment of diabetes related conditions such as CVD, hypertension 
and lipids, pharmacology for diabetes such as OHA and insulin.  Participants were 
then asked about the availability of, and access to, CPD, and if they had undertaken 
any CPD to meet their needs as a prescriber since qualifying.  
 
Ethical approval 
The Berkshire Research Ethics Committee and the University of Reading Ethics 
Committee granted ethical approval for the study. Each questionnaire was coded with 
a unique identifier number (which corresponded to each of the names of the 
NIPs/NSPs selected at random from the NMC database) and distributed via the NMC 
to the home address of participants. Respondents returned completed questionnaires  
in the SAE which was addressed to Reading University. Return of a completed 
questionnaire was taken as consent to participate.  
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Data collection  
One thousand nine hundred and ninety two nurses were selected at random from all 
(n=8000) nurses registered on the NMC database of NIPs/NSPs.  Based on the 
findings and the response rates of previous national surveys (Latter et al. 2005, 
Courtenay et al. 2007a), it was anticipated that a 70% response rate would be 
achieved of whom 30% of respondents would prescribe medicines for people with 
diabetes.  This large sample was required to ensure that each one of the broad range of 
settings in which nurses prescribe medicines for people with diabetes was represented.  
 
A letter outlining the purpose of the study (and what would be required of them), an 
information sheet, and a copy of the questionnaire were sent to participants. The letter 
informed participants that the study was completely voluntary, that responses were 
strictly confidential, that information collected from the questionnaire would be made 
anonymous, and that no identifying information would emanate from the research. 
After one follow up reminder questionnaire, 1400 (70%) questionnaires were 
returned, of which 1377 were completed. Twenty three were not completed as 
participants were no longer working in practice or were working abroad. Of the 1377 
completed questionnaires, 439 participants prescribed for diabetic patients. This paper 
reports on the findings for these 439 nurses.  
 
Data analysis 
Microsoft Excel and SPSS version 12 were used for data entry and analysis. 
Descriptive statistics were used to describe the demographic nature of the sample. Chi 
square tests were used to investigate the relationship between CPD needs, job title, 
grade/band and area of work.  
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RESULTS 
Demographic details 
The demographic data of the sample including job title, grade/band, part/full time 
work, area of work, age, academic qualification, time since qualified as NIP/NSP and 
years of experience in area of practice before undertaking the prescribing course are 
presented in Table 1.  
 
Specialist qualification 
Two hundred and forty four (55 %) participants had undertaken diploma, degree and 
or masters modules in diabetes. One hundred and eighty nine (46%) had attended 
university accredited study days. Ninety four (23%) had undergone informal training. 
This included visits to a specialist nurse or doctor working in a diabetes department, 
in-house training, and training provided by drug companies. Eighty two (20%) had 
not undertaken any specialist training in diabetes.  
 
 
CPD needs specific to diabetes prescribing practice 
Respondents were asked to specify CPD needs with respect to diabetes prescribing 
practices both within, and following the next 12 months.  The percentage of 
respondents who indicated that they had either no CPD needs, or CPD needs within, 
or after the next 12 months is shown in Table 2. The greatest requirement for CPD 
was an ‘update on prescribing policy’ with 42.5% (n=184) requiring this within the 
next 12 months and 30.7% (n=133) requiring it after 12 months.  The areas in which 
the least number of respondents indicated they required CPD were ‘assessment and 
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diagnosis of diabetes’, and ‘diabetes knowledge’ where 59.1% (n=256) and 43.9% 
(n=190) of respondents respectively reported that they had no CPD needs.  
 
Chi square was used to analyze the relationship between those respondents who 
reported that they did have CPD needs and job title, grade/band and area or work. The 
results are summarized on tables 3, 4 and 5. For all three variables there was 
insufficient evidence that the percentage of respondents with CPD needs varied to a 
significant degree across different levels of the variables (p=0.428, p=0.691, p=0.147 
respectively). Table 3 however, shows senior nurses/managers expressed less need for 
CPD (82%) compared with nurses in the remaining job title categories (87% or more). 
 
Is CPD available for you in your current prescribing role? 
Three hundred and fifty seven (83.8%) indicated that CPD was available, and 69 
(16.2%) that it was not. 
 
Are you able to access CPD to meet your needs as a prescriber? 
Three hundred and fifty seven (83.4%) reported that they had access to CPD to meet 
their needs as a prescriber, and 71 (16.6%) that they did not. Participants were asked 
to describe the reasons why they were unable to access CPD.  These problems were 
analysed using content analysis. Fifty seven responses were given. Eighty four 
percent (n=48) who reported no access indicated that this was due to a lack of 
facilities or funding, and 16% (n=9) as a result of workload or timing of the sessions.  
 
 15 
Have you undertaken any CPD to meet your needs as a prescriber since 
qualifying? 
Eighty percent (n=341) reported that they had undertaken CPD to meet their needs as 
a prescriber since qualifying, 20% (n=88) reported they had not. 
 
DISCUSSION 
Before summarizing the key findings and drawing conclusions, a potential limitation 
of the study must be taken in to account.  Respondents were asked to report on their 
CPD needs along with any problems they had experienced in accessing CPD. It would 
have been helpful to have also asked respondents to indicate their CPD needs and 
problems with access to CPD in the last 6 months. The majority of respondents had 
been qualified in excess of 2 years. Therefore, problems they had initially encountered 
accessing CPD may now not exist. This additional data would have provided a fuller 
picture about the provision of CPD in current practice.  
 
The majority of nurses in this sample  held an academic  qualification at degree level 
or higher, had over 5 years experience in their area of practice before NIP/NSP, work 
full time, were based in primary care and worked in general practice. These findings 
are consistent with those in previous studies reported by Courtenay et al. (2007a) and 
Latter et al. (2005). More than 75% of nurses sampled in these two studies reported 
that their highest qualification was at degree level or above. These studies, like ours, 
also identified large numbers of nurse prescribers working in primary care and general 
practice.  
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In comparison to previous findings, 63% of nurses in our study worked in general 
practice (compared to 39% reported by Latter et al.  (2005) and 50% reported by 
Courtenay et al. (2007a). Additionally, only 5.3% participants in our sample reported 
they worked as senior nurses. This compares with 14% reported by Latter et al. 
(2005) and 10.7% reported by Courtenay et al.(2007a).  
 
The senior nurses in our study reported fewer CPD needs. This finding is in line with 
those identified in  relatively recent review of education and training for health care 
staff and students  (Audit Commission 2001), and reported in previous research 
(Barriball & While 1996, Nolan et al. 2000). For example, it was evident from the 
380 nurses interviewed by Barriball & While (1996) that several groups of nurses 
were disadvantaged with respect to accessing CPD. This included those on lower 
grades. It is also evident from the 236 interviews undertaken by Nolan et al. (2000) 
that nurses who worked on night duty were disadvantaged with respect to accessing 
CPD. Senior nurses, who are more likely to work office hours, are perhaps therefore 
better placed to access CPD to meet their needs. The majority of our sample worked 
in other settings and had a number of CPD needs, therefore it is important that various 
modes of delivery (i.e. face to face, distance learning, and electronic formats) are used 
to provide nurse prescribers with access to CPD for diabetes. 
 
 
The higher number of nurses in our sample who worked in general practice provides 
some evidence that the responsibility for the care of people with diabetes has shifted 
from hospitals in to primary care. This finding is consistent  with policy literature 
(DoH 2005, DoH 2007) i.e. over the last 10 years government policy has been to 
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deliver services closer to people’s home in the community and to shift care away from 
the hospital (DoH 2007). Long term conditions (including diabetes) are areas 
emphasised in the Quality and Outcomes Framework of the new General Medical 
Services Contract (DoH 2005). The majority of nurses in our sample worked in 
general practice. This therefore provides some evidence that nurse prescribing is 
being used to support the services provided by GPs for patients with these conditions.  
 
Over 80% of the participants in our study reported they had accessed CPD to support 
their current prescribing role. This is higher than that reported by Courtenay et al. 
(2007a) and Latter et al (2005) i.e. less than 60% of participants in these studies 
reported they had undertaken CPD since qualifying to prescribe. Only 20% of our 
sample had been unable to access CPD i.e. 12% lower than the 32% reported by 
Courtenay et al. (2007a). Nearly 60% of our sample reported that they had no CPD 
needs specific to diabetes prescribing. This is considerably higher than findings 
reported by Latter et al. (2005). Only 28% of the nurses surveyed by these researchers 
reported that they had no CPD needs.  Our findings suggest that there has been 
considerable and recent improvement to the provision of CPD to meet the needs of 
nurses who prescribe medicines for patients with diabetes. This is in line with recent 
NMC guidance (NMC 2008) which stipulates that the employer should ensure that 
practitioners have access to relevant  on going education and training provision.  This 
provision may take a number of forms including e-learning, prescribing forums, 
formal CPD study days and action learning sets. However it is possible that our 
findings also reflect the established CPD opportunities that are available to healthcare 
professionals in the area of diabetes management.  
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Over 40% of nurses in our study who indicated that they had CPD needs specific to 
diabetes prescribing within or after the next 12 months, reported that this was in the 
areas of prescribing policy, pharmacology for diabetes, and the management and 
treatment of diabetes related conditions such as CVD, hypertension and lipids. This is 
in contrast to previous reports on the CPD needs of nurse prescribers (Latter et al. 
2005, Courtenay et al. 2007a).  Although not specifically reporting on the need for 
CPD in the area of diabetes management, only 21% of participants in Courtenay et 
al.’s (2007a) study reported similar CPD needs to the nurses in our study (i.e. 
pharmacology, update on prescribing policy and treatment management of conditions.   
In comparison, nearly 60% of the nurses surveyed by Latter et al. (2005) had general 
(but unspecified) CPD needs specific to the prescribing role. 
 
A large proportion of our sample who had CPD needs reported that this was in the 
area of pharmacology for diabetes (including insulin’s and oral hypoglycaemic 
agents). Whilst it might perhaps be expected that DSNs would require information on 
new specialist drugs for diabetes (e.g. incretin hormones), 63% of our sample worked 
in GP. It is possible, therefore, that this need for knowledge surrounding insulin’s and 
oral hypoglycaemic agents reflects wider policy changes to the organisation of 
diabetes care at a local and national level (DoH 2007), whereby nurses in general 
practice are becoming increasingly involved with the initiation of insulin therapy, and 
the management of more complex patients with diabetes.  Although not in the area of 
diabetes management, the need for more pharmacological training has previously 
been reported by DN/HV prescribers (Otway 2002, Sodha et al. 2002). For example, 
the most prominent educational need identified by 80% of participants surveyed in 
Otway’s (2002) study was pharmacological knowledge. Similarly Sodha et al. (2002) 
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in a survey of community nurses, identified that the 83% of nurse prescribers 
surveyed had inadequate pharmacological knowledge to undertake their role as a 
prescriber. Despite improved access to CPD, it is evident that nurse prescribers have 
ongoing needs for pharmacological knowledge. Further research exploring the 
specific pharmacological needs of nurse prescribers is therefore warranted.  
 
The fact that the majority of our sample reported CPD needs in the management and 
treatment of diabetes related conditions such as CVD, hypertension and lipids perhaps 
provides further evidence of the rapid pace of change that has occurred in the NHS, 
and the role many nurses now play in the management of some of the common 
complications associated with patients with diabetes. These findings are also in line 
with previous research (New et al. 2003, Denver et al. 2003). In these two RCTs 
nurses used protocols to titrate medicines of nearly 1700 patients with diabetes in 
order to manage their hypertension, hyperlipidemia and CVD. 
 
Given the numerous and recent legislative changes surrounding the prescription of 
medicines by nurses (DoH 2006), the need for an update on prescribing policy by a 
such a large proportion of our sample is unsurprising.  It is possible therefore that this 
reflects the rapid pace of policy change that nurses have experienced, whereby they 
still feel the need to have regular updates in this area. 
 
Over 50% of nurses in our sample reported that they held a specialist qualification in 
diabetes. This finding perhaps explains the lower number of nurses reporting CPD 
needs in the more general areas of diabetes knowledge, management and treatment, 
assessment and diagnosis. Our findings are in contrast to those reported by Courtenay 
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et al. (2007a) where only 7% of the nurses surveyed who prescribed medicines for 
skin conditions reported a specialist module in dermatology. Our findings are 
consistent with policy  (NMC 2006). The NMC guidelines stipulate that nurses need 
to acquire to specialist knowledge prior to undertaking the prescribing programme 
(NMC 2006). It is likely therefore, that these more general areas of diabetes 
knowledge would be covered in specialist accredited modules provided by 
universities and institutes of higher education.  
 
CONCLUSION 
NIP and NSP have extended the role that nurses in the UK have in the management of 
care for patients with diabetes. This care is predominantly provided by nurses 
working in general practice. However, if nurses are to provide high quality evidence 
based care it is evident that they must have access to CPD. It is evident from our 
findings that there have been recent improvements to the provision of CPD for nurse 
prescribers. However, the level of nurses pharmacological knowledge, and the 
provision of CPD to meet this need continue to be areas which warrant further 
investigation. 
 
RELEVANCE TO CLINICAL PRACTICE 
 Previous concerns have been identified about the provision of CPD to meet the needs 
of nurse prescribers. The findings from this study indicate that there has been 
considerable improvement to the provision of CPD for nurse prescribers who care for 
patients with diabetes. However, pharmacological knowledge is still the greatest CPD 
requirement of nurses who prescribe for patients with diabetes. Education providers 
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may wish to consider developing the content of CPD programmes to meet these 
needs. 
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TABLES  
Table 1: Demographic characteristics 
 
 
 
             n=number of 
responses 
% of total 
sample 
Job Title  
General practice   
(practice nurses and nurse practitioners) 
275 62.8 
Specialist nurses   
(clinical nurse specialists, specialist nurse practitioners, nurse 
clinicians, children’s nurses and midwives) 
77 17.6 
Community Nurses  
(community/modern matron, HV, DN, community children’s nurse 
specialist, community psychiatric nurses and learning disabilities) 
63 14.4 
Senior Nurses  
(nurse consultants, senior nurses, charge nurses, sisters, manager) 
23 5.3 
Grade/Band  
Grade E or Band 5 2 0.5 
Grade F/G or Band 6 115 26.7 
Grade H or Band 7 195 44.4 
Grade I or Band 8/9 or Nurse Partner  104 23.7 
Part time/full time  
<20 hrs per week 39 6.9 
21-30 per week 142 32.6 
Full time i.e. >30 hrs per week 264 60 
Primary/and or Secondary Care  
Primary care 369 84.2 
Secondary Care 43 9.8 
Primary and Secondary Care 26 5.9 
Age   
<35 years  28 6.4 
36-45 years 171 39 
46-55 years 191 43.6 
55-65 years 48 11 
Academic Qualification   
Certificate level 16 3.6 
Diploma level 66 15 
Degree level 247 56.3 
Master level 110 25.1 
Time since Qualified as NIP/NSP   
< 6 months 13 3 
6-12 months 56 12.9 
1-2 years 146 34.2 
> 2 years 213 49.9 
Experience in area of practice before NIP/NSP   
< 1 year 10 2.4 
1-2 years 28 6.6 
2-5 years 69 16.2 
> 5 years 318 74.8 
Percents do not add to 100%  in each category as some participants 
 did not complete every question 
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Table 2: Continuing Professional Development (CPD) needs specific to diabetes prescribing  
CPD need  (%responding from 433) 
None 
Need within 
12 months 
Need after 
12 months 
n % n % n % 
Update on prescribing policy 116 26.8 184 42.5 133 30.7 
Pharmacology for diabetes, such as OHA and 
insulin 
190 31.6 107 42.7 136 25.6 
Management and treatment of diabetes 
related conditions such as CVD, hypertension 
and lipids 
256 35.1 54 31.4 123 33.5 
Management and treatment of diabetes 176 40.6 116 26.8 141 32.6 
Diabetes knowledge 152 43.9 136 24.7 145 31.4 
Assessment and diagnosis of diabetes 137 59.1 185 12.5 111 28.4 
 
Table 3.  Whether CPD needs vary across job title categories 
 
Job title 
     Any CPD needs  
No      Yes 
Total n= n % n % 
General Practice 24 8.9 247 91.1 271 
Community Nurse 7 11.1 56 88.9 63 
Secondary Care 10 13.2 66 86.8 76 
Senior Nurses/Managers 4 18.2 18 81.8 22 
Total 45 10.4 387 89.6 432 
 
Table 4.  Whether CPD needs vary across grade/band 
 
Grade/Band 
     Any CPD needs  
No      Yes 
Total n= n % n % 
E/5,F/6/G 11 9.6 104 90.4 115 
H/7 24 12.4 170 87.6 194 
I/8,9, Nurse partner 10 9.9 91 90.1 101 
Total 45 11 365 89 410 
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Table 5.  Whether CPD needs vary across area of work 
 
Area of work 
     Any CPD needs  
No      Yes 
Total n= n % n % 
Primary Care 34 9.3 330 90.7 364 
Secondary Care 8 19 34 81.0 42 
Both primary and 
secondary care 
3 11.5 23 88.5 26 
Total 45 10.4 387 89.6 432 
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